Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression.

Saved in:
Bibliographic Details
Title: Decitabine promotes degradation of DNMT1 and EZH2 via the ubiquitination pathway and inhibits colorectal cancer progression.
Authors: Peng, Xiao-Mei1 (AUTHOR), Shi, Xin-Peng2 (AUTHOR), Chen, Han2 (AUTHOR), Cao, Lu-Yang3 (AUTHOR), Zuo, Hao-Jian4 (AUTHOR), Guo, Jie-Qiong5 (AUTHOR), Jiang, Nan6 (AUTHOR), Luo, Xiao-Yong2 (AUTHOR) zlklxy68@163.com
Source: Cellular Oncology (2211-3428). Feb2026, Vol. 49 Issue 1, p1-16. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:22113428
DOI:10.1007/s13402-025-01136-8